Description

In this episode, we discuss breast cancer screening quality measure. We delve into the data behind breast cancer screening, learn how modern imaging technology, outdated clinical trials, and evolving guidelines impact the effectiveness and risks of mammograms. We also explore how making this into a quality measure exacerbates the harms from false positives, overdiagnosis, and radiation exposure while disincentivizing shared decision-making between doctor and patient.